论文部分内容阅读
目的:在对经皮冠状动脉介入术治疗急性心肌梗死临床价值进行客观评定的基础上,研究可改善急性心肌梗死病人预后水平的方法。方法:采取随机法选择本院2012年10月至2015年10月接收的113例急性心肌梗死病人(实验组),本组接受经皮冠状动脉介入术治疗;同期选择113例急性心肌梗死病人(对照组)进行对照,本组接受溶栓治疗,对2组入选病人的临床效果进行客观对比,同时评定其左心射血分数、住院时长、不良症状、血管再通几率等指标。结果:完成治疗后,实验组入选病人左心射血分数、住院时长、血管再通几率等方面都比对照组更有优势,2组对比后发现有差距(P<0.05)。结论:选择经皮冠状动脉介入术治疗急性心肌梗死可取得显著疗效,可推广。
Objective: To evaluate the clinical value of percutaneous coronary intervention in the treatment of acute myocardial infarction on the basis of objective, to study the prognosis of patients with acute myocardial infarction improved method. Methods: A total of 113 patients with acute myocardial infarction (experimental group) received from our hospital from October 2012 to October 2015 were selected. The patients underwent percutaneous coronary intervention (PCI). 113 patients with acute myocardial infarction Control group) .This group received thrombolytic therapy, objectively comparing the clinical effects of the two groups of selected patients, while assessing the left ventricular ejection fraction, length of hospital stay, adverse symptoms, recanalization rate and other indicators. Results: After the completion of treatment, left ventricular ejection fraction, length of hospital stay and rate of recanalization in the experimental group were superior to the control group. There was a significant difference between the two groups (P <0.05). Conclusion: The treatment of acute myocardial infarction by percutaneous coronary intervention can achieve a significant effect and can be promoted.